International guidelines

Rest of the world

Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline[40]

Published by:American Urological Association; Society of Urologic Oncology

Last published:2024

NCCN clinical practice guidelines in oncology: bladder cancer[43]

Published by:National Comprehensive Cancer Network

Last published:2024

ACR appropriateness criteria: pretreatment staging of urothelial cancer[65]

Published by:American College of Radiology

Last published:2024

Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline[111]

Published by:American Urological Association

Last published:2024

Guidelines on muscle-invasive and metastatic bladder cancer[53]

Published by:European Association of Urology

Last published:2024

Guidelines on non-muscle-invasive bladder cancer​​[47]

Published by:European Association of Urology

Last published:2023

Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer​[59]

Published by:Canadian Urological Association

Last published:2021

Microhematuria: AUA/SUFU guideline[51]

Published by:American Urological Association (AUA); Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)

Last published:2020

ACR appropriateness criteria: post-treatment surveillance of bladder cancer[80]

Published by:American College of Radiology

Last published:2020

ACR appropriateness criteria: hematuria​​​[52]

Published by:American College of Radiology

Last published:2019

Canadian Urological Association guideline: muscle-invasive bladder cancer[59]

Published by:Canadian Urological Association

Last published:2019

Use of this content is subject to our disclaimer